Literature DB >> 23532360

Gender differences in cholinergic and dopaminergic deficits in Parkinson disease.

Vikas Kotagal1, Roger L Albin, Martijn L T M Müller, Robert A Koeppe, Kirk A Frey, Nicolaas I Bohnen.   

Abstract

As Parkinson disease (PD) may affect men and women differentially, we investigated gender differences in regional projection system integrity in 148 PD subjects (36 women, 112 men) using monoaminergic [11C]dihydrotetrabenazine and acetylcholinesterase [11C]PMP positron emission tomography. After controlling for age, disease duration, and Hoehn and Yahr score, men showed 5.9% greater caudate dopaminergic denervation (p = 0.0018) and 5.8% greater neocortical cholinergic denervation (p = 0.0097). No significant gender differences were seen in putaminal dopaminergic or thalamic cholinergic denervation.

Entities:  

Mesh:

Year:  2013        PMID: 23532360      PMCID: PMC3762897          DOI: 10.1007/s00702-013-1013-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  17 in total

1.  Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.

Authors:  R A Koeppe; K A Frey; D E Kuhl; M R Kilbourn
Journal:  J Cereb Blood Flow Metab       Date:  1999-12       Impact factor: 6.200

2.  Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity.

Authors:  S E Snyder; L Tluczek; D M Jewett; T B Nguyen; D E Kuhl; M R Kilbourn
Journal:  Nucl Med Biol       Date:  1998-11       Impact factor: 2.408

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin; Robert A Koeppe; Kristine A Wernette; Michael R Kilbourn; Satoshi Minoshima; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2006-01-18       Impact factor: 6.200

5.  A simple synthesis of [11C]dihydrotetrabenazine (DTBZ).

Authors:  D M Jewett; M R Kilbourn; L C Lee
Journal:  Nucl Med Biol       Date:  1997-02       Impact factor: 2.408

6.  Gender differences in Parkinson's disease.

Authors:  Charlotte A Haaxma; Bastiaan R Bloem; George F Borm; Wim J G Oyen; Klaus L Leenders; Silvia Eshuis; Jan Booij; Dean E Dluzen; Martin W I M Horstink
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-10       Impact factor: 10.154

7.  Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study.

Authors:  L M L de Lau; P C L M Giesbergen; M C de Rijk; A Hofman; P J Koudstaal; M M B Breteler
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

8.  Distribution volume ratios without blood sampling from graphical analysis of PET data.

Authors:  J Logan; J S Fowler; N D Volkow; G J Wang; Y S Ding; D L Alexoff
Journal:  J Cereb Blood Flow Metab       Date:  1996-09       Impact factor: 6.200

9.  Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey
Journal:  J Cereb Blood Flow Metab       Date:  2012-05-09       Impact factor: 6.200

10.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Authors:  Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J Van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

View more
  7 in total

1.  Clinical markers for identifying cholinergic deficits in Parkinson's disease.

Authors:  Martijn L T M Müller; Nicolaas I Bohnen; Vikas Kotagal; Peter J H Scott; Robert A Koeppe; Kirk A Frey; Roger L Albin
Journal:  Mov Disord       Date:  2014-11-12       Impact factor: 10.338

2.  Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen
Journal:  Neurology       Date:  2014-03-28       Impact factor: 9.910

Review 3.  Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Authors:  Kentaro Hirao; Gregory M Pontone; Gwenn S Smith
Journal:  Neurosci Biobehav Rev       Date:  2014-11-20       Impact factor: 8.989

4.  Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease.

Authors:  Marina Picillo; David-Erick LaFontant; Susan Bressman; Chelsea Caspell-Garcia; Christopher Coffey; Hyunkeun Ryan Cho; Elliot L Burghardt; Nabila Dahodwala; Rachel Saunders-Pullman; Caroline M Tanner; Amy W Amara
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Sexual Dysfunctions in Parkinson's Disease and Their Influence on Partnership-Data of the PRISM Study.

Authors:  Thomas Kinateder; Daniela Marinho; Doreen Gruber; Laura Hatzler; Georg Ebersbach; Florin Gandor
Journal:  Brain Sci       Date:  2022-01-25

6.  Sex differences in Parkinson's Disease: An emerging health question.

Authors:  Luiz Philipe de Souza Ferreira; Rafael André da Silva; Matheus Marques Mesquita da Costa; Vinicius Moraes de Paiva Roda; Santiago Vizcaino; Nilma R L L Janisset; Renata Ramos Vieira; José Marcos Sanches; José Maria Soares Junior; Manuel de Jesus Simões
Journal:  Clinics (Sao Paulo)       Date:  2022-10-01       Impact factor: 2.898

7.  Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease.

Authors:  Marta San Luciano; Cuiling Wang; Roberto A Ortega; Nir Giladi; Karen Marder; Susan Bressman; Rachel Saunders-Pullman
Journal:  Ann Clin Transl Neurol       Date:  2017-10-19       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.